A\u011fciy\u0259rd\u0259 h\u00fcceyr\u0259l\u0259rin balanss\u0131z \u00e7oxalmas\u0131 n\u0259tic\u0259sind\u0259 yaranan b\u0259dxass\u0259li \u015fi\u015f formasiyalar\u0131na a\u011fciy\u0259r x\u0259r\u00e7\u0259ngi deyilir. X\u0259r\u00e7\u0259ng h\u00fcceyr\u0259l\u0259ri \u0259vv\u0259lc\u0259 olduqlar\u0131 yerd\u0259 \u00e7oxal\u0131r v\u0259 k\u00fctl\u0259 \u0259m\u0259l\u0259 g\u0259tirir. \u0130r\u0259li m\u0259rh\u0259l\u0259l\u0259r\u0259 g\u0259ldikd\u0259, \u0259trafdak\u0131 toxuma v\u0259 orqanlara yay\u0131l\u0131r. A\u011fciy\u0259r x\u0259r\u00e7\u0259ngi \u0259n \u00e7ox yay\u0131lm\u0131\u015f x\u0259r\u00e7\u0259ng n\u00f6vl\u0259rind\u0259 biridir v\u0259 ciddi n\u0259tic\u0259l\u0259r\u0259 s\u0259b\u0259b olur. Ad\u0259t\u0259n erk\u0259n m\u0259rh\u0259l\u0259l\u0259rd\u0259 simptomlara s\u0259b\u0259b olmad\u0131\u011f\u0131ndan, diaqnoz qoyulduqda x\u0259st\u0259lik tez-tez ir\u0259lil\u0259yir. Bu s\u0259b\u0259bd\u0259n risk alt\u0131nda olan \u015f\u0259xsl\u0259rin m\u00fct\u0259madi olaraq, m\u00fcayin\u0259l\u0259rd\u0259n ke\u00e7m\u0259l\u0259ri son d\u0259r\u0259c\u0259 vacibdir.<\/p>\n\n\n\n

A\u011fciy\u0259r X\u0259r\u00e7\u0259nginin \u018flam\u0259tl\u0259ri N\u0259l\u0259rdir?<\/h2>\n\n\n\n

A\u011fciy\u0259r x\u0259r\u00e7\u0259nginin simptomlar\u0131 x\u0259st\u0259lik ir\u0259lil\u0259dikc\u0259 g\u00f6r\u00fcnm\u0259y\u0259 ba\u015flay\u0131r. X\u0259st\u0259liyin erk\u0259n m\u0259rh\u0259l\u0259l\u0259rind\u0259 ad\u0259t\u0259n dem\u0259k olar ki, he\u00e7 bir \u0259lam\u0259t v\u0259 ya simptom m\u00fc\u015fahid\u0259 olunmur. \u00dcmumi olaraq is\u0259 a\u011fciy\u0259r x\u0259r\u00e7\u0259nginin \u0259n \u00e7ox g\u00f6r\u00fcl\u0259n \u0259lam\u0259tl\u0259rini a\u015fa\u011f\u0131dak\u0131 kimi s\u0131ralamaq olar: <\/p>\n\n\n\n

• Davaml\u0131 olan v\u0259 getdikc\u0259 pisl\u0259\u015f\u0259n \u00f6sk\u00fcr\u0259k;<\/li>
• Qanl\u0131 b\u0259l\u011f\u0259m;<\/li>
• S\u0259s bo\u011fuqlu\u011fu;<\/li>
• Udma zaman\u0131 \u00e7\u0259tinlik;<\/li>
• \u0130\u015ftahs\u0131zl\u0131q;<\/li>
• Ani v\u0259 s\u00fcr\u0259tli ar\u0131qlama kimi s\u0131ralana bil\u0259r. <\/li><\/ul>\n\n\n\n

  Bu \u0259lam\u0259t v\u0259 simptomlar il\u0259 a\u011fciy\u0259r x\u0259r\u00e7\u0259ngi \u00f6z\u00fcn\u00fc biruz\u0259 ver\u0259 bilir. \u018fg\u0259r sizd\u0259 d\u0259 yuxar\u0131dak\u0131 \u0259lam\u0259tl\u0259r varsa, \u0259n q\u0131sa zamanda h\u0259kim\u0259 m\u00fcraci\u0259t etm\u0259yinizd\u0259 fayda vard\u0131r.<\/p>\n\n\n\n

  <\/figure>\n\n\n\n

  A\u011fciy\u0259r X\u0259r\u00e7\u0259nginin Yaranma S\u0259b\u0259bl\u0259ri N\u0259l\u0259rdir?<\/h2>\n\n\n\n

  A\u011fciy\u0259r x\u0259r\u00e7\u0259nginin yaranma s\u0259b\u0259bl\u0259rind\u0259n \u0259n \u00e7ox m\u00fc\u015fahid\u0259 olunan\u0131 siqaretdir. Siqaret \u00e7\u0259km\u0259k a\u011fciy\u0259r x\u0259r\u00e7\u0259ngi \u00fc\u00e7\u00fcn \u0259n b\u00f6y\u00fck risk faktorudur. Bununla bel\u0259, a\u011fciy\u0259r x\u0259r\u00e7\u0259ngi h\u0259yat\u0131 boyu siqaret \u00e7\u0259km\u0259y\u0259n insanlarda da yarana bil\u0259r. \u00dcmumiyy\u0259tl\u0259 siqaret dem\u0259k olar ki, b\u00fct\u00fcn x\u0259st\u0259likl\u0259rin 85%-d\u0259n \u00e7oxuna s\u0259b\u0259b olur. Ara\u015fd\u0131rmalar n\u0259tic\u0259sind\u0259 m\u00fc\u0259yy\u0259n olunmu\u015fdur ki, g\u00fcnd\u0259 25-d\u0259n \u00e7ox siqaret \u00e7\u0259k\u0259n insanlar he\u00e7 vaxt \u00e7\u0259km\u0259y\u0259nl\u0259r\u0259 nisb\u0259t\u0259n a\u011fciy\u0259r x\u0259r\u00e7\u0259ngin\u0259 tutulma riski 25 d\u0259f\u0259 \u00e7oxdur. <\/p>\n\n\n\n

  Siqaret \u00e7\u0259km\u0259k t\u0259kc\u0259 a\u011fciy\u0259r x\u0259r\u00e7\u0259nginin deyil, h\u0259m d\u0259 dig\u0259r x\u0259r\u00e7\u0259ng n\u00f6vl\u0259rinin, m\u0259s\u0259l\u0259n, qida borusu v\u0259 a\u011f\u0131z bo\u015flu\u011funun x\u0259r\u00e7\u0259nginin d\u0259 yaranma s\u0259b\u0259bidir. Passiv siqaret \u00e7\u0259km\u0259k d\u0259 a\u011fciy\u0259r x\u0259r\u00e7\u0259ngi riskini art\u0131r\u0131r. H\u0259yat yolda\u015f\u0131 siqaret \u00e7\u0259k\u0259n insanlar\u0131n a\u011fciy\u0259r x\u0259r\u00e7\u0259ngin\u0259 tutulma riskinin siqaret \u00e7\u0259km\u0259y\u0259nl\u0259r\u0259 nisb\u0259t\u0259n 25% daha \u00e7ox oldu\u011fu m\u00fc\u0259yy\u0259n edilmi\u015fdir. <\/p>\n\n\n\n

  A\u011fciy\u0259r x\u0259r\u00e7\u0259nginin ba\u015fqa bir s\u0259b\u0259bi d\u0259 asbestin m\u0259ruz qalmas\u0131d\u0131r. Asbest istiliy\u0259 v\u0259 a\u015f\u0131nmaya davaml\u0131, kanserogen x\u00fcsusiyy\u0259tl\u0259r\u0259 malik lifli minerald\u0131r. Z\u0259r\u0259rli t\u0259siri bilinm\u0259y\u0259nd\u0259 istilik v\u0259 s\u0259s izolyasiyas\u0131 \u00fc\u00e7\u00fcn geni\u015f istifad\u0259 edil\u0259n asbest indi s\u00f6k\u00fclm\u0259 zaman\u0131 i\u015f\u00e7il\u0259r z\u0259r\u0259rli t\u0259sirl\u0259rin\u0259 m\u0259ruz qal\u0131r.<\/p>\n\n\n\n

  <\/figure>\n\n\n\n

  A\u011fciy\u0259r X\u0259r\u00e7\u0259nginin Hans\u0131 N\u00f6vl\u0259ri Var?<\/h2>\n\n\n\n

  A\u011fciy\u0259rd\u0259 ba\u015flayan v\u0259 \u0259traf toxuma v\u0259 orqanlara yay\u0131lan x\u0259r\u00e7\u0259ng\u0259 ilkin a\u011fciy\u0259r x\u0259r\u00e7\u0259ngi deyilir. X\u0259r\u00e7\u0259ng b\u0259d\u0259nin ba\u015fqa yerind\u0259 ba\u015flay\u0131rsa v\u0259 a\u011fciy\u0259rl\u0259r\u0259 yay\u0131l\u0131rsa, buna ikincil a\u011fciy\u0259r x\u0259r\u00e7\u0259ngi deyilir.<\/p>\n\n\n\n

  Birincil a\u011fciy\u0259r x\u0259r\u00e7\u0259nginin m\u00fcxt\u0259lif n\u00f6vl\u0259ri var v\u0259 onlar ki\u00e7ik h\u00fcceyr\u0259li a\u011fciy\u0259r x\u0259r\u00e7\u0259ngi v\u0259 ki\u00e7ik h\u00fcceyr\u0259li olmayan a\u011fciy\u0259r x\u0259r\u00e7\u0259ngi kimi iki \u0259sas qrupa b\u00f6l\u00fcn\u00fcr. H\u0259r 100 hadis\u0259d\u0259n t\u0259xmin\u0259n 12-si ki\u00e7ik h\u00fcceyr\u0259li a\u011fciy\u0259r x\u0259r\u00e7\u0259ngi qrupunda (12%) a\u015fkar edilir. Ad\u0259t\u0259n bu x\u0259r\u00e7\u0259ng n\u00f6v\u00fc siqaretd\u0259n qaynaqlan\u0131r v\u0259 \u00e7ox erk\u0259n yay\u0131lma\u011fa meyillidir. <\/p>\n\n\n\n

  A\u011fciy\u0259r x\u0259r\u00e7\u0259ngl\u0259rinin \u0259ks\u0259riyy\u0259ti ki\u00e7ik h\u00fcceyr\u0259li olmayan x\u0259r\u00e7\u0259ngl\u0259rdir (88%). Bu qrupdak\u0131 x\u0259r\u00e7\u0259ngl\u0259r bir az daha xo\u015fxass\u0259li x\u00fcsusiyy\u0259tl\u0259r n\u00fcmayi\u015f etdirirl\u0259r. \u00dc\u00e7 \u00fcmumi alt n\u00f6v var. Onlar eyni \u015f\u0259kild\u0259 davrand\u0131qlar\u0131na v\u0259 m\u00fcalic\u0259y\u0259 eyni reaksiya verdiyin\u0259 g\u00f6r\u0259 qrupla\u015fd\u0131r\u0131l\u0131blar. Bu \u00fc\u00e7 x\u0259r\u00e7\u0259ng n\u00f6v\u00fc adenokarsinoma, skuam\u00f6z h\u00fcceyr\u0259li karsinoma v\u0259 b\u00f6y\u00fck h\u00fcceyr\u0259li karsinoma kimi siyah\u0131ya al\u0131n\u0131r.<\/p>\n\n\n\n

  <\/figure>\n\n\n\n

  A\u011fciy\u0259r X\u0259r\u00e7\u0259ngi Nec\u0259 M\u00fcalic\u0259 Olunmal\u0131d\u0131r?<\/h2>\n\n\n\n

  A\u011fciy\u0259r x\u0259r\u00e7\u0259nginin m\u00fcalic\u0259si x\u0259st\u0259nin \u00fcmumi sa\u011flaml\u0131q d\u0259r\u0259c\u0259sind\u0259n, x\u0259r\u00e7\u0259ngin n\u00f6v\u00fc v\u0259 m\u0259rh\u0259l\u0259si d\u0259 daxil olmaqla, bir s\u0131ra amill\u0259rd\u0259n as\u0131l\u0131 olaraq d\u0259yi\u015fir. \u00dcmumiyy\u0259tl\u0259 x\u0259r\u00e7\u0259ng x\u0259st\u0259likl\u0259rinin m\u00fcalic\u0259sind\u0259 c\u0259rrahiyy\u0259, radioterapiya, kimyaterapiya v\u0259 immunoterapiya kimi m\u00fcxt\u0259lif m\u00fcalic\u0259 variantlar\u0131 vard\u0131r. Bu m\u00fcalic\u0259l\u0259r t\u0259k v\u0259 ya bir ne\u00e7\u0259 il\u0259 birlikd\u0259 t\u0259tbiq oluna bil\u0259r. \u018fg\u0259r a\u011fciy\u0259r x\u0259r\u00e7\u0259ngi x\u0259st\u0259sinizs\u0259 v\u0259 ya x\u0259st\u0259lik \u00fc\u00e7\u00fcn risk qrupundas\u0131n\u0131zsa, m\u00fcnt\u0259z\u0259m olaraq m\u00fcayin\u0259 plan\u0131 \u00fc\u00e7\u00fcn sa\u011flaml\u0131q m\u00fc\u0259ssis\u0259sin\u0259 m\u00fcraci\u0259t etm\u0259yinizi v\u0259 laz\u0131mi analizl\u0259r verm\u0259yinizi, m\u00fcalic\u0259 plan\u0131n\u0131 t\u0259tbiq etm\u0259yinizi t\u00f6vsiy\u0259 edirik.<\/p>\n\n

  <\/div>","protected":false},"excerpt":{"rendered":"

  A\u011fciy\u0259rd\u0259 h\u00fcceyr\u0259l\u0259rin balanss\u0131z \u00e7oxalmas\u0131 n\u0259tic\u0259sind\u0259 yaranan b\u0259dxass\u0259li \u015fi\u015f formasiyalar\u0131na a\u011fciy\u0259r x\u0259r\u00e7\u0259ngi deyilir. X\u0259r\u00e7\u0259ng h\u00fcceyr\u0259l\u0259ri \u0259vv\u0259lc\u0259 olduqlar\u0131 yerd\u0259 \u00e7oxal\u0131r v\u0259 k\u00fctl\u0259 \u0259m\u0259l\u0259 g\u0259tirir. \u0130r\u0259li m\u0259rh\u0259l\u0259l\u0259r\u0259 g\u0259ldikd\u0259, \u0259trafdak\u0131 toxuma v\u0259 orqanlara yay\u0131l\u0131r. A\u011fciy\u0259r x\u0259r\u00e7\u0259ngi \u0259n \u00e7ox yay\u0131lm\u0131\u015f x\u0259r\u00e7\u0259ng n\u00f6vl\u0259rind\u0259 biridir v\u0259 ciddi n\u0259tic\u0259l\u0259r\u0259 s\u0259b\u0259b olur. Ad\u0259t\u0259n erk\u0259n m\u0259rh\u0259l\u0259l\u0259rd\u0259 simptomlara s\u0259b\u0259b olmad\u0131\u011f\u0131ndan, diaqnoz qoyulduqda x\u0259st\u0259lik tez-tez ir\u0259lil\u0259yir. Bu… \u018ftrafl\u0131 \u00bbA\u011fciy\u0259r X\u0259r\u00e7\u0259ngi N\u0259dir? X\u0259st\u0259liyin \u018flam\u0259tl\u0259ri v\u0259 M\u00fcalic\u0259 \u00dcsullar\u0131 N\u0259dir?<\/span><\/a><\/p>\n","protected":false},"author":3,"featured_media":558,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"neve_meta_sidebar":"","neve_meta_container":"","neve_meta_enable_content_width":"","neve_meta_content_width":0,"neve_meta_title_alignment":"","neve_meta_author_avatar":"","neve_post_elements_order":"","neve_meta_disable_header":"","neve_meta_disable_footer":"","neve_meta_disable_title":"","neve_meta_reading_time":"","_ti_tpc_template_sync":false,"_ti_tpc_template_id":"","footnotes":""},"categories":[517],"tags":[768,756,762,763,765,767,766,764,755,758,761,769,760,757,759],"yoast_head":"\n